eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2013
vol. 9
 
Share:
Send email
Share:
abstract:

Special papers
Myocardial infarction caused by pharmacological substances – case description and literature review

Tomasz Kameczura
,
Leszek Bryniarski
,
Sławomir Surowiec
,
Maryla Kocowska
,
Kalina Kawecka-Jaszcz
,
Danuta Czarnecka

Postep Kardiol Inter 2013; 9, 3 (33): 250–255
DOI: https://doi.org/10.5114/pwki.2013.37504
Online publish date: 2013/09/16
View full text Get citation
 
Myocardial infarction (MI) is most commonly caused by atherosclerosis and/or inflammatory processes of coronary artery walls. The consequence of those phenomena is instability of the atherosclerotic plaque, activation of the coagulation cascade and thrombus formation which occludes the lumen of the vessel. Vasospasm and microembolisation may participate in MI pathogenesis. In young individuals with diagnosis of MI, coronarography often reveals no pathologies. Is reported that MIs without significant changes of the coronary arteries occur in 1% to 12% of patients. In this article we focus on chemical substances, medicines among them, which can be a cause of MI.
keywords:

myocardial infarction, myocardial infarction causes, pharmacotherapy
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.